Aspen Pharmacare Holdings (JSE:APN) has seen its average one-year price target updated to R146.20 per share, marking a 21.81% increase from the previous estimate of R120.02, dated February 21, 2026. The new targets range from a low of R116.15 to a high of R183.75, though this represents a decrease of 98.86% from its latest reported closing price of R12,794.00.
The company’s dividend yield currently stands at 0.02%, with a negative payout ratio of -0.47, indicating that Aspen is not maintaining a healthy dividend policy. Over the last quarter, institutional ownership in Aspen has decreased by 98.04%, with only two funds reporting positions, totaling 83,000 shares—down 99.72% in three months.
Invesco FTSE RAFI Emerging Markets ETF holds 75,000 shares, reflecting a 61.90% increase from its previous holding of 29,000 shares, while Africa Fund holds 8,000 shares with no change in the last quarter.
